Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $6.1700 (-4.19%) ($6.1700 - $6.1700) on Fri. Feb. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.97% (three month average) | RSI | 49 | Latest Price | $6.1700(-4.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -2.7% a day on average for past five trading days. | Weekly Trend | CEMI declines -3.5% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) XLC(-36%) VXX(5%) UNG(-14%) XAR(-56%) SIL(-14%) | Factors Impacting CEMI price | CEMI will decline at least -2.485% in a week (0% probabilities). XRT(-21%) ICLN(-94%) IDRV(-32%) INDA(-64%) IBB(-39%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.485% (StdDev 4.97%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.04 | 5 Day Moving Average | $6.77(-8.86%) | 10 Day Moving Average | $7.18(-14.07%) | 20 Day Moving Average | $7.04(-12.36%) | To recent high | -22.2% | To recent low | 22.5% | Market Cap | $124m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |